Articles that mention Heather Bresch -BoardProspects

Heather Bresch

0 Comments Leave a Comment

1-5 of 5
1. Mentioned In 5 Articles
2. Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member ...
  
  Explore Google Jul 29 2019 BoardNews
  
  HERTFORDSHIRE, England and PITTSBURGH, July 29, 2019 /PRNewswire/ -- Mylan's Board of Directors today shared the following statement...
  Read Full Article
  
  Comment
  
  Mentions: Mylan Heather Bresch CEO
3. Mylan : More than a Third of Mylan investors Voted Against Chairman
  
  Explore 4-traders : one website, all markets Jun 28 2017 BoardNews
  
  ... regulators on Wednesday. Investors also cast more than a quarter of the shares voted against Chief Executive Heather Bresch, in the wake of a scandal over high prices for its EpiPen emergency allergy treatment. The comp...
  Read Full Article
  
  Comment
  
  Mentions: Board Chair Annual Meeting Mylan
4. Investors Pushing Back Over Executive Pay at Mylan
  
  Explore usatoday.com May 31 2017 BoardNews
  
  ...n a toll. In the past 12 months, a period of time that includes the appearance before Congress of current CEO Heather Bresch to explain Mylan's decision to hike prices on some drugs, shares have fallen 10%. Shares have f...
  Read Full Article
  
  Comment
  
  Mentions: Mylan stock options Congress
5. Women CEOs Don't Get Paid Less Than Men in Big Business, They Make More
  
  Explore 4-traders : one website, all markets May 31 2017 BoardNews
  
  ... posting -29%. The drugmaker faced a furor over hefty price increases for its lifesaving EpiPen. Longtime CEO Heather Bresch received $13.8 million last year, down from $18.9 million the previous year. "We place a clear ...
  Read Full Article
  
  Comment
  
  Mentions: Mylan Meg Whitman stock options
6. Women Leaders Help Corporate America Make Big Bucks
  
  Explore NASDAQ Stock Market Mar 2 2016 BoardNews
  
  ...pharmaceutical ingredients (APIs) worldwide. Market cap at $22.12B, most recent closing price at $60.81. CEO: Heather Bresch. Target price: $60.81. Projected EPS growth (next year vs. this year): 12.15% compared to indus...
  Read Full Article
  
  Comment
  
  Mentions: Corporate Performance Investment Bloomberg
7. 1-5 of 5